Guidelines in a Nutshell: GINA 2024: How to improve long-term outcomes for people with asthma.

ASTHMA treatment; ADRENOCORTICAL hormones; PULMONARY function tests; PROFESSIONAL practice; PATIENT safety; SPIROMETRY; DISEASE management; EVALUATION of medical care; RESPIRATORY diseases; SINUSITIS; OVERTREATMENT; SLEEP apnea syndromes

The article focuses on the findings of GINA 2024, the latest update to the Global Initiative for Asthma report, for the management of patients with respiratory illness. GINA defines the level of asthma control as the extent to which the features of asthma can be observed in the patient, or have been reduced or removed by treatment. It is suggested that control should be assessed in two parts: symptom control and the risk of adverse outcomes.